Yu XF - Search Results

1

HIV-2/SIV Vpx targets a novel functional domain of STING to selectively inhibit cGAS-STING-mediated NF-κB signalling.

Su J, Rui Y, Lou M, Yin L, Xiong H, Zhou Z, Shen S, Chen T, Zhang Z, Zhao N, Zhang W, Cai Y, Markham R, Zheng S, Xu R, Wei W, Yu XF. Su J, et al. Among authors: yu xf. Nat Microbiol. 2019 Dec;4(12):2552-2564. doi: 10.1038/s41564-019-0585-4. Epub 2019 Oct 28. Nat Microbiol. 2019. PMID: 31659299

2

A naturally immunogenic virion-associated protein specific for HIV-2 and SIV.

Yu XF, Ito S, Essex M, Lee TH. Yu XF, et al. Nature. 1988 Sep 15;335(6187):262-5. doi: 10.1038/335262a0. Nature. 1988. PMID: 2842694

3

Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users.

Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Markham RB, et al. J Infect Dis. 1995 Apr;171(4):797-804. doi: 10.1093/infdis/171.4.797. J Infect Dis. 1995. PMID: 7706805

4

Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells.

Markham RB, Schwartz DH, Templeton A, Margolick JB, Farzadegan H, Vlahov D, Yu XF. Markham RB, et al. Among authors: yu xf. J Virol. 1996 Oct;70(10):6947-54. doi: 10.1128/JVI.70.10.6947-6954.1996. J Virol. 1996. PMID: 8794338 Free PMC article.

5

Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users.

Yu XF, Wang Z, Vlahov D, Markham RB, Farzadegan H, Margolick JB. Yu XF, et al. J Infect Dis. 1998 Aug;178(2):388-96. doi: 10.1086/515646. J Infect Dis. 1998. PMID: 9697718

6

Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.

Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF. Markham RB, et al. Among authors: yu xf. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12568-73. doi: 10.1073/pnas.95.21.12568. Proc Natl Acad Sci U S A. 1998. PMID: 9770526 Free PMC article.

7

Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand.

Wang Z, Lyles CM, Beyrer C, Celentano DD, Vlahov D, Natpratan C, Markham R, Khamboonruang C, Nelson K, Yu XF. Wang Z, et al. Among authors: yu xf. J Infect Dis. 1998 Nov;178(5):1507-11. doi: 10.1086/314441. J Infect Dis. 1998. PMID: 9780276

8

Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha.

Khanna KV, Yu XF, Ford DH, Ratner L, Hildreth JK, Markham RB. Khanna KV, et al. Among authors: yu xf. J Immunol. 2000 Feb 1;164(3):1408-15. doi: 10.4049/jimmunol.164.3.1408. J Immunol. 2000. PMID: 10640756

9

Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals.

Templeton AR, Reichert RA, Weisstein AE, Yu XF, Markham RB. Templeton AR, et al. Among authors: yu xf. Genetics. 2004 Aug;167(4):1547-61. doi: 10.1534/genetics.103.023945. Genetics. 2004. PMID: 15342497 Free PMC article.

10

Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity.

Xu R, Dong Q, Yu Y, Zhao X, Gan X, Wu D, Lu Q, Xu X, Yu XF. Xu R, et al. Among authors: yu xf, yu y. Leuk Res. 2006 Jan;30(1):17-23. doi: 10.1016/j.leukres.2005.05.023. Epub 2005 Jul 14. Leuk Res. 2006. PMID: 16023722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters